Want to see IN:VENUSREM full AI Analyst Report?
Total Valuation
Venus Remedies Limited has a market cap or net worth of ₹20.94B. The enterprise value is ₹10.13K.
Market Cap₹20.94B
Enterprise Value₹10.13K
Share Statistics
Venus Remedies Limited has 13,366,988 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,366,988
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Venus Remedies Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 13.44%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)13.44%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee6.48M
Profits Per Employee865.88K
Employee Count1,187
Asset Turnover0.90
Inventory Turnover3.88
Valuation Ratios
The current PE Ratio of Venus Remedies Limited is 18.2. Venus Remedies Limited’s PEG ratio is 0.08.
PE Ratio18.2
PS Ratio1.42
PB Ratio1.65
Price to Fair Value1.65
Price to FCF9.16
Price to Operating Cash Flow25.12
PEG Ratio0.08
Income Statement
In the last 12 months, Venus Remedies Limited had revenue of 7.70B and earned 1.03B in profits. Earnings per share was 76.89.
Revenue7.70B
Gross Profit2.68B
Operating Income1.22B
Pretax Income1.34B
Net Income1.03B
EBITDA1.60B
Earnings Per Share (EPS)76.89
Cash Flow
In the last 12 months, operating cash flow was 811.10M and capital expenditures -128.90M, giving a free cash flow of 682.20M billion.
Operating Cash Flow811.10M
Free Cash Flow682.20M
Free Cash Flow per Share51.04
Dividends & Yields
Venus Remedies Limited pays an annual dividend of ₹10, resulting in a dividend yield of ―
Dividend Per Share₹10
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change205.38%
50-Day Moving Average1.67K
200-Day Moving Average995.00
Relative Strength Index (RSI)40.44
Average Volume (3m)2.33K
Important Dates
Venus Remedies Limited upcoming earnings date is Nov 14, 2026, TBA (Confirmed).
Last Earnings DateJul 20, 2026
Next Earnings DateNov 14, 2026
Ex-Dividend Date―
Financial Position
Venus Remedies Limited as a current ratio of 2.44, with Debt / Equity ratio of 1.87%
Current Ratio2.44
Quick Ratio1.64
Debt to Market Cap0.00
Net Debt to EBITDA-0.11
Interest Coverage Ratio3.04K
Taxes
In the past 12 months, Venus Remedies Limited has paid 313.70M in taxes.
Income Tax313.70M
Effective Tax Rate0.23
Enterprise Valuation
Venus Remedies Limited EV to EBITDA ratio is 6.74, with an EV/FCF ratio of 9.01.
EV to Sales1.40
EV to EBITDA6.74
EV to Free Cash Flow9.01
EV to Operating Cash Flow6.85
Balance Sheet
Venus Remedies Limited has ₹1.04B in cash and marketable securities with ₹124.10M in debt, giving a net cash position of ₹920.00M billion.
Cash & Marketable Securities₹1.04B
Total Debt₹124.10M
Net Cash₹920.00M
Net Cash Per Share₹68.83
Tangible Book Value Per Share₹426.24
Margins
Gross margin is 40.06%, with operating margin of 15.80%, and net profit margin of 13.35%.
Gross Margin40.06%
Operating Margin15.80%
Pretax Margin17.43%
Net Profit Margin13.35%
EBITDA Margin20.77%
EBIT Margin17.44%
Analyst Forecast
The average price target for Venus Remedies Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast20.87%
EPS Growth Forecast116.29%